Brunswick Corp. (BC) Drops 7.45% on January 15

Equities Staff |

Brunswick Corp. (BC) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 7.45% to $37.94, a loss of $-3.055 per share. Starting at an opening price of $39.87 a share, the stock traded between $36.89 and $39.87 over the course of the trading day. Volume was 3.39 million shares over 25,233 trades, against an average daily volume of 932,725 shares and a total float of 91.05 million.

The losses send Brunswick Corp. down to a market cap of $3.45 billion. In the last year, Brunswick Corp. has traded between $56.63 and $40.72, and its 50-day SMA is currently $51.10 and 200-day SMA is $51.11.

The stock has a P/E Ratio of 15.7.

Brunswick Corp is engaged in designing, manufacturing and marketing of recreation products including marine engines, boats, fitness and billiards equipment. Its products include sterndrive, yachts, deck boats, marine parts and cardiovascular equipment.

Brunswick Corp. is based out of Lake Forest, IL and has some 12,165 employees. Its CEO is Dustan E. Mccoy.

For a complete fundamental analysis analysis of Brunswick Corp., check out’s Stock Valuation Analysis report for BC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.